Molina Healthcare (MOH) has been a central topic in various reportings recently. High medical care costs might negatively impact Molina's Q2 earnings, yet the company saw strong trading volume. It won a new Florida Medicaid contract and shows a subdued P/E potentially signalling an opportunity. The company beat profit estimates due to increased premiums and an overall growth in membership. Various entities like Twin Tree Management, Sei Investments and others increased their holdings in Molina. The company posted a strong earning growth in Q4 and full-year 2023, with an adjusted EPS that exceeded expectations amidst a surge in revenue. However, Molina's price target was cut to $400.00 by analysts at Truist Financial. Despite some fluctuations, the firm saw a CAGR of 16% over the last five years. A downgrade was linked to potential challenges under a Trump presidency. Yet, the stocks are projected to rise fueled by strategies driving strong future growth. Additionally, the company acquired Bright Healthcareβs California Medicare Business and won a Michigan Medicaid Contract. While there were some stocks sold, overall, the company's growth trajectory remains strong.
Molina Healthcare MOH News Analytics from Fri, 30 Jun 2023 07:00:00 GMT to Sun, 21 Jul 2024 13:48:13 GMT -
Rating 7
- Innovation -3
- Information 7
- Rumor 4
